本页面由Tiger Trade Technology Pte. Ltd.提供服务

Spring Bank Pharmaceuticals, Inc.

1.21
0.0000
成交量:- -
成交额:- -
市值:522.33万
市盈率:-0.18
高:1.21
开:1.21
低:1.21
收:1.21
52周最高:19.20
52周最低:1.21
股本:431.68万
流通股本:372.71万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-6.5410
每股收益(LYR):-5.8580
净资产收益率:-90.61%
总资产收益率:-33.74%
市净率:0.29
市盈率(LYR):-0.21

数据加载中...

2021/02/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/01/25

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/01/04

重要事件披露

8-K - Current report
2020/12/04

重要事件披露

8-K - Current report
2020/12/03

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/11/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/30

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/25

重要事件披露

8-K - Current report
2020/11/20

重要事件披露

8-K - Current report
2020/11/09

企业合并公告

425 - Prospectuses and communications, business combinations
2020/11/09

重要事件披露

8-K - Current report
2020/11/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/15

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/30

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/12

企业合并公告

425 - Prospectuses and communications, business combinations
2020/08/12

重要事件披露

8-K - Current report
2020/08/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]